25 XP   0   0   10

Zhejiang Shapuaisi Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Shapuaisi Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Shapuaisi Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Shapuaisi Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Shapuaisi Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Shapuaisi Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Shapuaisi Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
59.0%

What is your share worth?

Current worth
¥4.70
Expected worth in 1 year
¥5.72
How sure are you?
87.2%

+ What do you gain per year?

Total Gains per Share
¥1.13
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
¥10.11
Expected price per share
¥7.4567 - ¥11.88
How sure are you?
50%

1. Valuation of Zhejiang Shapuaisi Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥10.11

Intrinsic Value Per Share

¥-15.83 - ¥-18.98

Total Value Per Share

¥-11.13 - ¥-14.28

2. Growth of Zhejiang Shapuaisi Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Shapuaisi Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$246.8m$190.9m$51.7m21.3%

How much money is Zhejiang Shapuaisi Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.7m$1.5m$1.2m44.1%
Net Profit Margin11.7%7.9%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Shapuaisi Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Shapuaisi Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Shapuaisi Pharmaceutical Co Ltd is ¥10.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Shapuaisi Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.70. Based on the TTM, the Book Value Change Per Share is ¥0.25 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.010.1%0.010.1%0.000.0%0.010.1%
Usd Book Value Change Per Share0.000.0%0.040.3%0.010.1%0.000.0%0.020.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.1%
Usd Total Gains Per Share0.000.0%0.040.4%0.010.1%0.000.0%0.020.2%
Usd Price Per Share1.36-1.21-1.23-1.16-3.15-
Price to Earnings Ratio153.27-59.84-60.64-128.37-112.40-
Price-to-Total Gains Ratio439.58-147.68-251.99-170.86-225.39-
Price to Book Ratio2.10-1.89-2.45-2.15-8.55-
Price-to-Total Gains Ratio439.58-147.68-251.99-170.86-225.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.399224
Number of shares714
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.040.00
Usd Total Gains Per Share0.040.00
Gains per Quarter (714 shares)27.922.17
Gains per Year (714 shares)111.708.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11110010245-1
2232012147108
334301326111517
445402438142026
557502550182635
668602662213144
779703774253653
891803886284162
9102903998324671
1011310041110365180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%34.05.00.087.2%34.05.00.087.2%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%29.010.00.074.4%29.010.00.074.4%
Dividend per Share4.00.00.0100.0%5.00.07.041.7%8.00.012.040.0%23.00.016.059.0%23.00.016.059.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%34.05.00.087.2%34.05.00.087.2%

Fundamentals of Zhejiang Shapuaisi Pharmaceutical Co Ltd

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.

Fundamental data was last updated by Penke on 2024-03-27 21:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Shapuaisi Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 3.9% means that ¥0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 3.9%. The company is making a profit. +1
  • The TTM is 11.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ3.9%TTM11.7%-7.8%
TTM11.7%YOY7.9%+3.8%
TTM11.7%5Y-12.3%+23.9%
5Y-12.3%10Y3.1%-15.3%
1.1.2. Return on Assets

Shows how efficient Zhejiang Shapuaisi Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Assets means that Zhejiang Shapuaisi Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.0%-0.7%
TTM1.0%YOY0.7%+0.3%
TTM1.0%5Y-0.7%+1.7%
5Y-0.7%10Y1.3%-2.0%
1.1.3. Return on Equity

Shows how efficient Zhejiang Shapuaisi Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.3% Return on Equity means Zhejiang Shapuaisi Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM1.1%-0.8%
TTM1.1%YOY0.8%+0.3%
TTM1.1%5Y-0.8%+2.0%
5Y-0.8%10Y1.7%-2.5%

1.2. Operating Efficiency of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Shapuaisi Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Shapuaisi Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.7%-9.7%
TTM9.7%YOY7.5%+2.2%
TTM9.7%5Y-1.6%+11.3%
5Y-1.6%10Y-0.5%-1.0%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Shapuaisi Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.50 means that the operating costs are ¥1.50 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 1.503. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.346. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.503TTM1.346+0.157
TTM1.346YOY1.324+0.022
TTM1.3465Y1.435-0.089
5Y1.43510Y0.893+0.543

1.3. Liquidity of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Shapuaisi Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.71 means the company has ¥2.71 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 2.707. The company is able to pay all its short-term debts. +1
  • The TTM is 3.086. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.707TTM3.086-0.380
TTM3.086YOY3.267-0.180
TTM3.0865Y5.617-2.530
5Y5.61710Y3.277+2.340
1.3.2. Quick Ratio

Measures if Zhejiang Shapuaisi Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.16 means the company can pay off ¥0.16 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.159. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.314. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.159TTM0.314-0.156
TTM0.314YOY0.921-0.607
TTM0.3145Y1.698-1.384
5Y1.69810Y1.561+0.137

1.4. Solvency of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Shapuaisi Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.14 means that Zhejiang Shapuaisi Pharmaceutical Co Ltd assets are financed with 14.2% credit (debt) and the remaining percentage (100% - 14.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.142. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.131. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.142TTM0.131+0.011
TTM0.131YOY0.112+0.019
TTM0.1315Y0.108+0.023
5Y0.10810Y0.144-0.035
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Shapuaisi Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 16.7% means that company has ¥0.17 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The MRQ is 0.167. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.152. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.152+0.015
TTM0.152YOY0.127+0.025
TTM0.1525Y0.125+0.027
5Y0.12510Y0.184-0.059

2. Market Valuation of Zhejiang Shapuaisi Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Shapuaisi Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Shapuaisi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 153.27 means the investor is paying ¥153.27 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The EOD is 157.157. Based on the earnings, the company is expensive. -2
  • The MRQ is 153.271. Based on the earnings, the company is expensive. -2
  • The TTM is 59.845. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD157.157MRQ153.271+3.886
MRQ153.271TTM59.845+93.426
TTM59.845YOY60.642-0.797
TTM59.8455Y128.369-68.524
5Y128.36910Y112.403+15.966
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The EOD is -10.731. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.466. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.315. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.731MRQ-10.466-0.265
MRQ-10.466TTM-7.315-3.151
TTM-7.315YOY-169.177+161.862
TTM-7.3155Y31.740-39.055
5Y31.74010Y37.937-6.196
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Shapuaisi Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Shapuaisi Pharmaceutical Co Ltd:

  • The EOD is 2.149. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.096. Based on the equity, the company is underpriced. +1
  • The TTM is 1.886. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.149MRQ2.096+0.053
MRQ2.096TTM1.886+0.209
TTM1.886YOY2.450-0.564
TTM1.8865Y2.148-0.261
5Y2.14810Y8.552-6.405
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Shapuaisi Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0200.254-92%0.037-45%0.013+56%0.121-83%
Book Value Per Share--4.7044.626+2%3.639+29%3.923+20%3.501+34%
Current Ratio--2.7073.086-12%3.267-17%5.617-52%3.277-17%
Debt To Asset Ratio--0.1420.131+8%0.112+27%0.108+31%0.144-1%
Debt To Equity Ratio--0.1670.152+10%0.127+31%0.125+34%0.184-9%
Dividend Per Share--0.0020.029-92%0.009-77%0.009-76%0.051-96%
Eps--0.0160.067-76%0.048-67%-0.022+235%0.043-63%
Free Cash Flow Per Share---0.236-0.090-62%-0.043-82%-0.024-90%0.027-986%
Free Cash Flow To Equity Per Share---0.2360.016-1589%-0.007-97%0.003-9112%0.094-350%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---18.984--------
Intrinsic Value_10Y_min---15.830--------
Intrinsic Value_1Y_max---0.451--------
Intrinsic Value_1Y_min---0.442--------
Intrinsic Value_3Y_max---2.461--------
Intrinsic Value_3Y_min---2.328--------
Intrinsic Value_5Y_max---5.805--------
Intrinsic Value_5Y_min---5.293--------
Market Cap3833327658.240+2%3738537162.2403309136215.360+13%3377385372.480+11%3166571309.376+18%8636342646.356-57%
Net Profit Margin--0.0390.117-67%0.079-51%-0.123+416%0.031+27%
Operating Margin---0.097-100%0.075-100%-0.0160%-0.0050%
Operating Ratio--1.5031.346+12%1.324+14%1.435+5%0.893+68%
Pb Ratio2.149+2%2.0961.886+11%2.450-14%2.148-2%8.552-75%
Pe Ratio157.157+2%153.27159.845+156%60.642+153%128.369+19%112.403+36%
Price Per Share10.110+2%9.8608.728+13%8.908+11%8.352+18%22.777-57%
Price To Free Cash Flow Ratio-10.731-3%-10.466-7.315-30%-169.177+1516%31.740-133%37.937-128%
Price To Total Gains Ratio450.721+2%439.576147.682+198%251.990+74%170.862+157%225.385+95%
Quick Ratio--0.1590.314-50%0.921-83%1.698-91%1.561-90%
Return On Assets--0.0030.010-70%0.007-60%-0.007+333%0.013-77%
Return On Equity--0.0030.011-70%0.008-57%-0.008+337%0.017-80%
Total Gains Per Share--0.0220.283-92%0.046-52%0.022+2%0.172-87%
Usd Book Value--246870474.174242738287.798+2%190966147.272+29%205861227.965+20%183712146.717+34%
Usd Book Value Change Per Share--0.0030.035-92%0.005-45%0.002+56%0.017-83%
Usd Book Value Per Share--0.6510.640+2%0.504+29%0.543+20%0.485+34%
Usd Dividend Per Share--0.0000.004-92%0.001-77%0.001-76%0.007-96%
Usd Eps--0.0020.009-76%0.007-67%-0.003+235%0.006-63%
Usd Free Cash Flow---12359593.408-4747584.650-62%-2240338.151-82%-1276544.565-90%1395193.931-986%
Usd Free Cash Flow Per Share---0.033-0.013-62%-0.006-82%-0.003-90%0.004-986%
Usd Free Cash Flow To Equity Per Share---0.0330.002-1589%-0.001-97%0.000-9112%0.013-350%
Usd Market Cap530532547.900+2%517413543.254457984452.206+13%467430135.551+11%438253469.218+18%1195269822.256-57%
Usd Price Per Share1.399+2%1.3651.208+13%1.233+11%1.156+18%3.152-57%
Usd Profit--843954.1832772300.956-70%1548957.184-46%-1486910.633+276%2102375.191-60%
Usd Revenue--21761999.30621933477.375-1%19759130.327+10%18429675.902+18%24007599.116-9%
Usd Total Gains Per Share--0.0030.039-92%0.006-52%0.003+2%0.024-87%
 EOD+5 -3MRQTTM+8 -27YOY+9 -265Y+20 -1410Y+10 -24

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15157.157
Price to Book Ratio (EOD)Between0-12.149
Net Profit Margin (MRQ)Greater than00.039
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.159
Current Ratio (MRQ)Greater than12.707
Debt to Asset Ratio (MRQ)Less than10.142
Debt to Equity Ratio (MRQ)Less than10.167
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.003
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.759
Ma 20Greater thanMa 509.991
Ma 50Greater thanMa 1009.943
Ma 100Greater thanMa 20010.637
OpenGreater thanClose10.120
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Operating Income  11,761-8,6733,08828,89831,986-2,00929,977-35,903-5,926
Net Interest Income  617-287330309639-467172-1,139-966



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,080,088
Total Liabilities296,341
Total Stockholder Equity1,773,994
 As reported
Total Liabilities 296,341
Total Stockholder Equity+ 1,773,994
Total Assets = 2,080,088

Assets

Total Assets2,080,088
Total Current Assets634,159
Long-term Assets1,445,928
Total Current Assets
Cash And Cash Equivalents 420,325
Short-term Investments 2,009
Net Receivables 35,177
Inventory 92,494
Other Current Assets 2,696
Total Current Assets  (as reported)634,159
Total Current Assets  (calculated)552,700
+/- 81,459
Long-term Assets
Property Plant Equipment 674,706
Goodwill 378,730
Intangible Assets 188,381
Long-term Assets Other 11,869
Long-term Assets  (as reported)1,445,928
Long-term Assets  (calculated)1,253,686
+/- 192,242

Liabilities & Shareholders' Equity

Total Current Liabilities234,306
Long-term Liabilities62,036
Total Stockholder Equity1,773,994
Total Current Liabilities
Short Long Term Debt 105,900
Accounts payable 36,343
Other Current Liabilities 1,012
Total Current Liabilities  (as reported)234,306
Total Current Liabilities  (calculated)143,255
+/- 91,051
Long-term Liabilities
Long term Debt 27,930
Capital Lease Obligations Min Short Term Debt33,386
Long-term Liabilities  (as reported)62,036
Long-term Liabilities  (calculated)61,316
+/- 720
Total Stockholder Equity
Retained Earnings 398,408
Total Stockholder Equity (as reported)1,773,994
Total Stockholder Equity (calculated)398,408
+/- 1,375,587
Other
Capital Stock379,062
Common Stock Shares Outstanding 379,062
Net Invested Capital 1,907,824
Net Working Capital 399,853
Property Plant and Equipment Gross 674,706



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
> Total Assets 
327,381
516,540
597,565
628,872
971,818
834,756
872,341
918,889
944,373
1,014,356
1,274,989
1,368,304
1,406,095
1,544,680
1,842,116
1,832,894
1,762,921
1,850,631
1,869,408
1,878,521
1,767,363
1,803,046
1,648,594
1,642,609
1,635,821
1,648,557
1,589,321
1,559,474
1,547,540
1,543,104
1,672,903
1,663,727
1,476,747
1,507,965
1,585,355
1,540,917
1,540,989
1,552,501
1,957,678
2,000,665
2,040,620
2,080,088
2,080,0882,040,6202,000,6651,957,6781,552,5011,540,9891,540,9171,585,3551,507,9651,476,7471,663,7271,672,9031,543,1041,547,5401,559,4741,589,3211,648,5571,635,8211,642,6091,648,5941,803,0461,767,3631,878,5211,869,4081,850,6311,762,9211,832,8941,842,1161,544,6801,406,0951,368,3041,274,9891,014,356944,373918,889872,341834,756971,818628,872597,565516,540327,381
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
852,588
896,129
911,470
916,797
920,596
944,303
929,825
911,734
914,139
926,246
647,647
654,988
608,757
549,721
553,948
437,192
414,333
392,465
727,805
648,182
652,489
634,159
634,159652,489648,182727,805392,465414,333437,192553,948549,721608,757654,988647,647926,246914,139911,734929,825944,303920,596916,797911,470896,129852,58800000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,146
139,019
145,164
203,469
191,187
189,879
223,489
262,099
705,397
382,446
106,781
219,403
194,592
151,671
138,524
258,588
197,081
180,840
525,059
440,241
409,204
420,325
420,325409,204440,241525,059180,840197,081258,588138,524151,671194,592219,403106,781382,446705,397262,099223,489189,879191,187203,469145,164139,019108,14600000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
450,000
0
450,000
0
459,000
0
260,000
260,000
0
350,000
250,000
150,000
150,000
100,000
105,030
20,000
40,342
20,033
29,272
12,043
12,009
2,009
2,00912,00912,04329,27220,03340,34220,000105,030100,000150,000150,000250,000350,0000260,000260,0000459,0000450,0000450,00000000000000000000000
       Net Receivables 
145,531
160,104
176,175
186,624
181,179
200,021
182,258
195,368
248,677
246,349
178,397
209,862
226,120
225,924
185,199
135,384
135,320
232,546
248,989
180,585
125,346
170,084
190,922
32,644
32,437
31,919
131,481
90,288
96,390
102,618
116,022
101,000
48,012
75,031
57,200
71,366
81,914
112,383
15,511
76,635
86,654
35,177
35,17786,65476,63515,511112,38381,91471,36657,20075,03148,012101,000116,022102,61896,39090,288131,48131,91932,43732,644190,922170,084125,346180,585248,989232,546135,320135,384185,199225,924226,120209,862178,397246,349248,677195,368182,258200,021181,179186,624176,175160,104145,531
       Other Current Assets 
20,064
14,159
4,225
8,932
3,152
109,300
3,404
90,340
12,333
48,002
33,252
34,143
35,781
108,509
9,576
214,302
15,404
217,571
39,556
443,033
49,683
471,491
34,219
447,981
478,507
473,528
29,529
207,029
22,540
20,628
18,310
118,621
175,193
174,666
192,371
26,329
36,880
19,473
9,174
41,752
53,880
2,696
2,69653,88041,7529,17419,47336,88026,329192,371174,666175,193118,62118,31020,62822,540207,02929,529473,528478,507447,98134,219471,49149,683443,03339,556217,57115,404214,3029,576108,50935,78134,14333,25248,00212,33390,3403,404109,3003,1528,9324,22514,15920,064
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
725,812
715,225
704,255
659,495
647,740
633,400
616,859
1,025,256
1,008,739
867,990
958,243
1,031,407
1,103,725
1,126,657
1,160,035
1,229,873
1,352,483
1,388,131
1,445,928
1,445,9281,388,1311,352,4831,229,8731,160,0351,126,6571,103,7251,031,407958,243867,9901,008,7391,025,256616,859633,400647,740659,495704,255715,225725,81200000000000000000000000
       Property Plant Equipment 
68,852
190,503
281,821
270,230
292,679
305,190
331,022
353,585
376,204
393,013
509,362
530,610
529,825
544,577
563,417
569,139
622,860
626,385
665,117
664,034
674,126
667,252
669,081
657,993
647,667
637,215
606,743
595,452
582,375
566,794
507,270
492,185
368,269
358,334
474,122
462,237
468,114
493,690
651,260
640,170
649,776
674,706
674,706649,776640,170651,260493,690468,114462,237474,122358,334368,269492,185507,270566,794582,375595,452606,743637,215647,667657,993669,081667,252674,126664,034665,117626,385622,860569,139563,417544,577529,825530,610509,362393,013376,204353,585331,022305,190292,679270,230281,821190,50368,852
       Goodwill 
0
0
0
0
0
0
0
0
0
0
228,784
228,784
228,784
228,784
228,784
228,784
228,784
228,784
178,157
178,157
178,157
178,157
0
0
0
0
0
0
0
0
336,158
336,158
336,158
336,158
336,158
336,158
336,158
336,158
326,683
378,019
378,730
378,730
378,730378,730378,019326,683336,158336,158336,158336,158336,158336,158336,158336,15800000000178,157178,157178,157178,157228,784228,784228,784228,784228,784228,784228,784228,7840000000000
       Intangible Assets 
26,539
25,828
593
31,119
30,904
30,707
30,524
31,379
31,138
30,897
289,560
288,907
288,183
287,444
286,737
285,996
285,256
284,679
235,604
234,801
55,842
55,119
66,623
66,171
14,005
64,517
51,145
50,336
49,583
48,829
177,287
176,282
157,758
157,408
165,718
165,408
164,102
163,015
160,142
158,925
158,536
188,381
188,381158,536158,925160,142163,015164,102165,408165,718157,408157,758176,282177,28748,82949,58350,33651,14564,51714,00566,17166,62355,11955,842234,801235,604284,679285,256285,996286,737287,444288,183288,907289,56030,89731,13831,37930,52430,70730,90431,11959325,82826,539
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
757
1,191
1,635
886
1,012
276
566,822
1,085
1,034
1,491
102,405
53,467
83,708
83,303
89,777
17,183
19,344
9,939
11,869
11,8699,93919,34417,18389,77783,30383,70853,467102,4051,4911,0341,085566,8222761,0128861,6351,19175700000000000000000000000
> Total Liabilities 
125,433
242,326
244,258
270,945
276,200
103,174
109,442
113,927
143,620
171,225
383,367
424,475
464,049
499,666
247,883
188,597
160,052
191,079
212,125
180,386
108,828
117,469
167,415
141,990
128,944
128,222
100,284
70,021
76,613
85,673
366,785
347,120
143,673
165,699
232,889
160,799
152,891
153,930
240,994
261,604
264,554
296,341
296,341264,554261,604240,994153,930152,891160,799232,889165,699143,673347,120366,78585,67376,61370,021100,284128,222128,944141,990167,415117,469108,828180,386212,125191,079160,052188,597247,883499,666464,049424,475383,367171,225143,620113,927109,442103,174276,200270,945244,258242,326125,433
   > Total Current Liabilities 
120,433
162,326
175,258
201,945
193,875
89,868
96,136
100,620
117,793
145,398
302,914
264,022
295,456
369,666
247,883
188,597
160,052
191,079
212,125
180,386
108,828
117,469
164,415
133,735
120,689
119,967
95,979
65,791
72,458
81,593
361,918
342,328
138,426
161,201
195,274
124,822
118,384
121,593
205,817
225,619
202,024
234,306
234,306202,024225,619205,817121,593118,384124,822195,274161,201138,426342,328361,91881,59372,45865,79195,979119,967120,689133,735164,415117,469108,828180,386212,125191,079160,052188,597247,883369,666295,456264,022302,914145,398117,793100,62096,13689,868193,875201,945175,258162,326120,433
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
105,900
105,90040,0000000000000000000000000000000000000000000
       Accounts payable 
11,861
45,241
16,182
20,614
24,931
33,526
33,549
43,859
47,548
42,809
28,800
27,322
45,825
69,274
26,971
33,438
29,609
28,518
50,272
38,470
36,611
41,102
41,028
37,603
44,040
38,051
34,287
19,274
15,351
18,855
33,875
44,458
29,734
26,479
25,927
26,156
24,161
29,654
80,854
93,509
37,687
36,343
36,34337,68793,50980,85429,65424,16126,15625,92726,47929,73444,45833,87518,85515,35119,27434,28738,05144,04037,60341,02841,10236,61138,47050,27228,51829,60933,43826,97169,27445,82527,32228,80042,80947,54843,85933,54933,52624,93120,61416,18245,24111,861
       Other Current Liabilities 
28,572
20,185
48,076
80,332
77,943
56,342
62,586
56,761
70,245
102,589
274,114
236,701
249,631
300,393
220,912
155,159
130,443
162,560
161,854
141,916
52,304
75,897
88,575
95,317
54,160
81,461
23,324
45,968
34,570
62,288
266,846
287,760
43,063
125,130
99,485
85,021
43,390
72,752
67,825
114,422
71,818
1,012
1,01271,818114,42267,82572,75243,39085,02199,485125,13043,063287,760266,84662,28834,57045,96823,32481,46154,16095,31788,57575,89752,304141,916161,854162,560130,443155,159220,912300,393249,631236,701274,114102,58970,24556,76162,58656,34277,94380,33248,07620,18528,572
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,255
8,255
8,255
4,305
4,230
4,155
4,080
4,867
4,792
5,247
4,498
37,615
35,977
34,507
32,337
35,177
35,985
62,530
62,036
62,03662,53035,98535,17732,33734,50735,97737,6154,4985,2474,7924,8674,0804,1554,2304,3058,2558,2558,25500000000000000000000000
       Other Liabilities 
0
0
0
0
13,326
13,306
13,306
13,306
25,827
25,827
30,453
30,453
38,593
0
0
0
0
0
0
0
0
0
3,000
8,255
8,255
8,255
4,305
4,230
4,155
4,080
4,867
4,792
2,242
2,242
0
0
0
0
1,421
1,421
39
0
0391,4211,42100002,2422,2424,7924,8674,0804,1554,2304,3058,2558,2558,2553,00000000000038,59330,45330,45325,82725,82713,30613,30613,30613,3260000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,371
2,996
2,622
2,247
1,873
6,629
5,998
5,367
0
4,897
5,133
0
05,1334,89705,3675,9986,6291,8732,2472,6222,9963,371000000000000000000000000000000
> Total Stockholder Equity
201,949
274,215
353,307
357,927
695,617
731,582
762,899
804,962
800,754
843,130
891,622
943,829
942,046
1,045,014
1,594,234
1,644,297
1,602,869
1,659,552
1,657,283
1,698,136
1,658,535
1,685,577
1,481,179
1,500,618
1,506,877
1,520,335
1,489,036
1,489,453
1,470,927
1,457,431
1,306,119
1,316,607
1,333,074
1,342,266
1,352,466
1,380,118
1,388,098
1,398,571
1,706,684
1,729,209
1,766,264
1,773,994
1,773,9941,766,2641,729,2091,706,6841,398,5711,388,0981,380,1181,352,4661,342,2661,333,0741,316,6071,306,1191,457,4311,470,9271,489,4531,489,0361,520,3351,506,8771,500,6181,481,1791,685,5771,658,5351,698,1361,657,2831,659,5521,602,8691,644,2971,594,2341,045,014942,046943,829891,622843,130800,754804,962762,899731,582695,617357,927353,307274,215201,949
   Common Stock
49,000
49,000
49,000
49,000
65,350
65,350
65,350
65,350
163,375
163,375
163,375
163,375
163,375
163,375
177,249
177,249
248,148
248,148
248,148
248,148
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
322,592
372,514
372,514
372,514
0
0372,514372,514372,514322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592322,592248,148248,148248,148248,148177,249177,249163,375163,375163,375163,375163,375163,37565,35065,35065,35065,35049,00049,00049,00049,000
   Retained Earnings 
98,989
162,166
230,850
268,299
299,247
335,212
366,529
408,592
339,034
381,410
429,902
482,109
480,326
583,294
651,706
701,769
651,595
708,278
714,755
755,608
716,007
743,049
538,651
449,775
456,033
469,492
546,508
546,925
528,399
514,903
363,591
374,079
390,546
399,738
399,247
426,899
434,879
445,351
332,730
467,709
504,764
398,408
398,408504,764467,709332,730445,351434,879426,899399,247399,738390,546374,079363,591514,903528,399546,925546,508469,492456,033449,775538,651743,049716,007755,608714,755708,278651,595701,769651,706583,294480,326482,109429,902381,410339,034408,592366,529335,212299,247268,299230,850162,16698,989
   Capital Surplus 000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue633,916
Cost of Revenue-274,760
Gross Profit359,156359,156
 
Operating Income (+$)
Gross Profit359,156
Operating Expense-574,791
Operating Income59,124-215,635
 
Operating Expense (+$)
Research Development71,304
Selling General Administrative183,335
Selling And Marketing Expenses-
Operating Expense574,791254,639
 
Net Interest Income (+$)
Interest Income2,740
Interest Expense--
Other Finance Cost-2,565
Net Interest Income175
 
Pretax Income (+$)
Operating Income59,124
Net Interest Income175
Other Non-Operating Income Expenses-
Income Before Tax (EBT)81,42259,124
EBIT - interestExpense = 0
80,124
80,124
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-81,422
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax81,422
Tax Provision-1,546
Net Income From Continuing Ops79,87679,876
Net Income80,124
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--175
 

Technical Analysis of Zhejiang Shapuaisi Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The general trend of Zhejiang Shapuaisi Pharmaceutical Co Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Shapuaisi Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.77 < 11.20 < 11.88.

The bearish price targets are: 8.62 > 7.5761 > 7.4567.

Tweet this
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current macd is 0.11441476.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Shapuaisi Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Shapuaisi Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Shapuaisi Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current adx is 21.70.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Shapuaisi Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current sar is 11.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current rsi is 51.76. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Shapuaisi Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current cci is 25.92.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current cmo is 3.72190845.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current willr is -71.71052632.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Shapuaisi Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Shapuaisi Pharmaceutical Co Ltd.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current atr is 0.54057874.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current obv is 180,590,177.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Shapuaisi Pharmaceutical Co Ltd. The current mfi is 50.28.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Shapuaisi Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Shapuaisi Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Zhejiang Shapuaisi Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Shapuaisi Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.759
Ma 20Greater thanMa 509.991
Ma 50Greater thanMa 1009.943
Ma 100Greater thanMa 20010.637
OpenGreater thanClose10.120
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Shapuaisi Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Shapuaisi Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Shapuaisi Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Shapuaisi Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Shapuaisi Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Shapuaisi Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Shapuaisi Pharmaceutical Co Ltd in your mailbox!